The role of the mTOR pathway in diabetic retinopathy.

Casciano, Fabio; Zauli, Enrico; Rimondi, Erika; Mura, Marco; Previati, Maurizio; Busin, Massimo; Zauli, Giorgio

Casciano, Fabio; Zauli, Enrico; Rimondi, Erika; Mura, Marco; Previati, Maurizio; Busin, Massimo; Zauli, Giorgio.

Afiliación

Casciano F; Department of Translational Medicine and LTTA Centre, University of Ferrara, Ferrara, Italy.
Zauli E; Interdepartmental Research Center for the Study of Multiple Sclerosis and Inflammatory and Degenerative Diseases of the Nervous System, University of Ferrara, Ferrara, Italy.
Rimondi E; Department of Translational Medicine, University of Ferrara, Ferrara, Italy.
Mura M; Department of Translational Medicine and LTTA Centre, University of Ferrara, Ferrara, Italy.
Previati M; Research Department, King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia.
Busin M; Department of Translational Medicine and LTTA Centre, University of Ferrara, Ferrara, Italy.
Zauli G; Department of Translational Medicine, University of Ferrara, Ferrara, Italy.

Front Med (Lausanne) ; 9: 973856, 2022.

Article en En | MEDLINE | ID: mdl-36388931

Palabras clave

autophagy; diabetic retinopathy; hyperglycemia; inflammation; mammalian target of rapamycin (mTOR); oxidative stress; reactive oxygen species (ROS); retinae

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Med (Lausanne) Año: 2022 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google